Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
LYL273 for Patients With Relapsed or Refractory mCRCNCT05319314LYELPhase 1, Phase 2Recruiting2028-06Estimated
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and AnemiaNCT05320198IRONPhase 1, Phase 2Recruiting2027-05Estimated
Study to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar LinesNCT05320393EOLSPhase 2Completed2023-05-22Actual
Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis SuppurativaNCT05322473MoonLake Immunotherapeutics AGPhase 2Completed2023-05-09Actual
Study of Epetraborole in Patients With Treatment-refractory MAC Lung DiseaseNCT05327803ANTXPhase 2, Phase 3Terminated2024-12-18Actual
Phase 2 Study of Plamotamab Combined With Tafasitamab Plus Lenalidomide Versus Tafasitamab Plus Lenalidomide in Relapsed or Refractory (R/R) Diffuse Large-cell B-cell Lymphoma (DLBCL)NCT05328102XNCRPhase 2Terminated2023-02-21Actual
A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract MalignanciesNCT05329766RCUSPhase 2Completed2026-09-07Actual
A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)NCT05335122OCULPhase 2Completed2024-01-24Actual
RNS System LGS Feasibility StudyNCT05339126NeuroPacePhase 2Active not recruiting2026-11-30Estimated
A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2)NCT05343455Journey Medical CorporationPhase 3Completed2023-06-30Actual
Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) DeficiencyNCT05345171RAREPhase 3Active not recruiting2027-09Estimated
Safety and Efficacy of CITI-002 in Adult Patients With Moderate Grade HemorrhoidsNCT05348200CTXRPhase 2Completed2023-04-20Actual
Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALSNCT05349721PTC TherapeuticsPhase 2Terminated2024-09-26Actual
Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPPNCT05352893Vanda PharmaceuticalsPhase 3Completed2023-08-17Actual
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe HypertriglyceridemiaNCT05355402IONSPhase 2Completed2023-03-22Actual
To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in Combination With Pembrolizumab in Adult Participants With Locally Advanced or Metastatic HER2-Expressing CancersNCT05356741VIRPhase 1, Phase 2Recruiting2028-04Estimated
A Phase IIb, Multi-Center, Multinational, Double-Blind, Placebo-Controlled Study, With an Open Label Extension, to Evaluate Safety, Tolerability and Efficacy of PrimeC in Subjects With ALSNCT05357950NRSNPhase 2Completed2023-11-02Actual
A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PDNCT05357989ANVSPhase 3Completed2023-12-04Actual
28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's DiseaseNCT05358821SUPNPhase 2Completed2024-02-29Actual
Trial of Atezolizumab and Bevacizumab With CHS-388 or Placebo in Patients With Hepatocellular CarcinomaNCT05359861CHRSPhase 2Terminated2025-06-30Actual
Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep DisturbancesNCT05361707Vanda PharmaceuticalsPhase 3Unknown2025-07Estimated
Administration of ARS-1 or Albuterol in Subjects With Persistent AsthmaNCT05363670SPRYPhase 2Completed2024-02-02Actual
Natrunix or Placebo in Combination With Methotrexate in Rheumatoid ArthritisNCT05363891XBITPhase 2Completed2024-10-31Actual
Study to Evaluate the Long-Term Safety and Efficacy of Imsidolimab (ANB019) in the Treatment of Subjects With GPPNCT05366855Vanda PharmaceuticalsPhase 3Terminated2024-07-12Actual
A Phase 2 Study of CDX-0159 in Patients With Chronic Spontaneous UrticariaNCT05368285Celldex TherapeuticsPhase 2Completed2023-09-28Actual
A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal AndrogensNCT05370521Spruce BiosciencesPhase 2Terminated2023-08-03Actual
A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)NCT05371613DNLIPhase 2, Phase 3Active not recruiting2027-12Estimated
Phase 3 Boosting Study for the SARS-CoV-2 rS Variant VaccinesNCT05372588NovavaxPhase 3Completed2022-07-17Actual
A Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 in Major Depressive DisorderNCT05376150XENEPhase 2Completed2023-09-18Actual
PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell LymphomaNCT05380635SoligenixPhase 2Completed2022-08-16Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.